EMEA: Overview of comments received on draft guideline on Carcinogenicity Evaluation of Medicinal Products for the Treatment of HIV Infection
25.03.2009
EMEA:
Overview of comments received on draft guideline on Carcinogenicity Evaluation of Medicinal Products for the Treatment of HIV Infection. This overview contains the general comments and specific comments.
Overview of comments received on draft guideline on Carcinogenicity Evaluation of Medicinal Products for the Treatment of HIV Infection. This overview contains the general comments and specific comments.
The source of the news: http://www.emea.europa.eu/pdfs/human/swp/21176207en.pdf
SciencePharma
